Zusammenfassung
Das gehäufte gemeinsame Auftreten und der Nachweis klinischer Gemeinsamkeiten von Epilepsie und Migräne werfen die Fragen nach einem gemeinsamen pathophysiologischen Modell der Erkrankungen auf. Jedoch fehlen bisher Hinweise für eine genetische Disposition der Komorbidität. Neuere klinische Studien bestätigen eine unspezifische Assoziation von Epilepsien und Migräne. Sie beruht am ehesten auf dem pathophysiologischen Mechanismus der "spreading depression" als ein Ausdruck für eine erhöhte zerebrale Erregbarkeit, die bei beiden Erkrankungen zu finden ist. Liegen beide Erkrankungen vor, bietet sich eine Migräneprophylaxe mit den Antikonvulsiva Valproinsäure, Gabapentin oder Topiramat an.
Summary
Increased co-occurrence and common clinical aspects of epilepsy and migraine lead to the question of a common pathophysiological model of the diseases. Shared genetic risk factors as an explanation for comorbidity could not be proven. Clinical studies underline the unspecific association of migraine and epilepsy. Comorbidity is based on spreading depression as an expression of altered brain state with neuronal hyperexcitability. In comorbid conditions, therapy with valproate, gabapentin, or topiramate may be effective.
Literatur
Afra J, Cecchini AP, De Pasqua V et al. (1998) Visual evoked potentials during long periods of pattern-reversal stimulation in migraine. Brain 121:233–241
Andermann F (2000) Migraine and the benign partial epilepsies of childhood: evidence for an association. Epileptic Disord 1:S37–39
Andermann E, Andermann F (1987) Migraine-epilepsy relationships: epidemiological and genetic aspects. In: Andermann F, Lugaresi E (eds) Migraine and epilepsy. Butterworths, Boston, pp 281–291
Aurora SK, Cao Y, Bowyer SM, Welch KMA (1999) The occipital cortex is hyperexcitable in migraine: experimental evidence. Headache 39:469–476
Barolin GS(1966) Migraines and epilepsies—a relationship? Epilepsia 7:53–66
Bazil CW (1994) Migraine and epilepsy. Neurol Clin 12:115–128
Bladin PF, Papworth G (1974) "Chuckling and gugging" seizures at night-sylvian spike epilepsy. Proc Australian Assoc Neurol 11:171–175
Camfield PR, Metrakos K, Andermann F (1978) Basilar migraine, seizures, and severe epileptiform abnormalities. Neurology 28:584–588
Cao Y, Welch KM, Aurora S, Vikingstad EM (1999) Functional MRI-BOLD of visually triggere headache in patients with migraine. Arch Neurol 56:548–554
Carlsson A, Forsgren L, Nylander PO et al. (2002) Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1. Neurology 59:1804–1807
De Romanis F, Buzzi MG, Cerbo R et al. (1991) Migraine and epilepsy with infantile onset and electroencephalogaphic findings of occipital spike-wave complexes. Headache 31:378–383
Ferrari MD, Odnuk J, Bos KD et al. (1990) Neuroexcitatory plasma acids are elevated in migraine. Neurology 40:1582–1586
Ferro JM, Melo TP, Oliveira V et al. (1995) A multivariate study of headache associated with ischemic stroke. Headache 35:315–319
Fletcher CF, Lutz CM, o'Sullivan TN et al. (1996) Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 87:607–617
Förderreuther S, Henkel A, Noachtar S, Straube A (2002) Headache associated with epileptic seizures: epidemiology and clinical characteristics. Headache 42:649–655
Freitag FG, Collins SD, Carlson HA et al. (2002) A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology 58:1652–1659
Galeotti N, Ghelardini C, Zoppi M et al. (2001) Hypofunctionality of Gi proteins as aetiopathogenic mechanism for migraine and cluster headache. Cephalalgia 21:38–45
Gorji A, Scheller D, Straub H et al. (2001) Spreading depression in human neocortical slices. Brain Res 906:74–83
Guipponi M, Rivier F, Vigevano F et al. (1997) Linkage mapping of benign familial infantile convulsions (BFIC) to chromosome 19q. Hum Mol Genet 6:473–477
Hauser AW, Annegers JF, Anderson EV et al. (1993) The incidence of epilepsy and unprovoked seizures in Rochesta, Minnesota. Epilepsia 34:453–463
Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 8 [Suppl 7]:1–96
Hering R, Kuritzky A (1992) Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia 12:81–84
Hirose S, Okada M, Kaneko S, Mitsudome A (2002) Molecular genetics of human familial epilepsy syndromes. Epilepsia 43 [Suppl 9]:21–25
Jensen R, Brinck T, Olesen J (1994) Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-crossover study. Neurology 44:647–651
Joutel A, Bousser MG, Biousse V et al. (1993) A gene for familial hemiplegic migraine maps to chromosome 19. Nature Genet 5:40–45
Klapper J, on behalf of the Divalproex Sodium in Migraine Prophylaxis Study Group (1997) Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia 17:103–108
Lampl C, Buzath A, Klinger D, Neumann K (1999) Lamotrigine in the prophylactic treatment of migraine aura- a pilot study. Cephalalgia 19:58–63
Lashley KS (1941) Patterns of cerebral integration indicated by scotomas of migraine. Arch Neurol Psychiatry 46:331–339
Lauritzen M (1994) Pathophysiology of the migraine aura. The spreading depression theory. Brain 118:199–210
Leao AAP (1944) Spreading depression of activity in the cerebral cortex. J Neurophysiol 7:359–390
Leniger T, Diener HC (1999) Migräne und Epilepsie—ein Zusammenhang? Akt Neurol 26:116–120
Leniger T, Diener HC (2000) Die Antikonvulsiva Valproinsäure, Gabapentin, Topiramat und Lamotrigin in der Migränetherapie. Akt Neurol 27:475–479
Leniger T, Isbruch K, von den Driesch S et al. (2001) Seizure-associated headache in epilepsy. Epilepsia 42:1176–1179
Leniger T, von den Driesch S, Isbruch K et al. (2003) Clinical characteristics of patients with comorbidity of migraine and epilepsy. Headache 43:672–677
Leppert M, Anderson VE, Quattlebaum T et al. (1989) Benign familial neonatal convulsions linked to genetic markers on chromosome 20. Nature 337:647–648
Lewis TB, Leach RJ, Ward K et al. (1993) Genetic heterogeneity in benign familial neonatal convulsions: identification of a new locus on chromosome 8q. Am J Hum Genet 53:670–675
Lipton RB, Ottman R (1994) Comorbidity of migraine: the connection between migraine and epilepsy. Neurology 44:28–32
Marks DA, Ehrenberg BL (1993) Migraine-related seizures in adults with epilepsy, with EEG correlation. Neurology 43:2476–2483
Martinovic Z, Cvorovic Z (1999) Migraine epilepsy syndromes: their evolution and treatment. Abstract. Cephalalgia 19:333
Mathew NT, Kailasam J, Meadors L (2002) Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate. Headache 42:796–803
Mathew NT, Saper JR, Silberstein SD et al. (1995) Migraine prophylaxis with divalproex. Arch Neurol 52:281–286
Mathew NT, Rapoport A, Saper J et al. (2001) Efficacy of gabapentin in migraine prophylaxis. Headache 41:119–128
Mulleners WM, Chronicle EP, Palmer JE et al. (2001) Visual cortex excitability in migraine with and without aura. Headache 41:565–572
Niedermeyer E (1993) Migraine-triggered epilepsy. Clin Electroencephalogr 24:37–43
Noble-Topham SE, Dyment DA, Cader MZ et al. (2002) Migraine with aura is not linked to the FHM gene CACNA1A or the chromosomal region, 19p13. Neurology 59:1099–1101
Ophoff RA, Terwindt GM, Vergouwe MN et al. (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87:543–552
Ottmann R, Lipton RB (1994) Comorbidity of migraine and epilepsy. Neurology 44:2105–2110
Pryse Phillips W, Findlay H, Tugwell P et al. (1992) A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Can J Neurol Sci 19:333–339
Rasmussen BK (1995) Epidemiology of headache. Cephalalgia 15:44–45
Rasmussen BK, Jensen R, Schroll M, Olesen J (1991) Epidemiology of headache in a general population—a prevalence study. J Clin Epidemiol 44:1147–1157
Russell MB (2001) Genetics of migraine without aura, migraine with aura, migrainous disorder, head trauma migraine without aura and tension-type headache. Cephalalgia 21:778–780
Schoenen J (1998) Cortical electrophysiology in migraine an dpossible pathogenetic implications. Clion Neurosci 5:10–17
Steiner TJ, Findley LJ, Yuen AWC (1997) Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 17:109–112
Terwindt GM, Ophoff RA, Lindhout D et al. (1997) Partial cosegregation of familial hemiplegic migraine and a benign familial infantil epileptic syndrome. Epilepsia 38:915–921
Von Seggern RL, Mannix LK, Adelman JU (2002) Efficacy of topiramate in migraine prophylaxis: a retrospective chart analysis. Headache 42:804–809
Welch KMA, Lewis D (1997) Migraine and epilepsy. Adv Headache 15:107–114
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Leniger, T., Diener, H.C. & Hufnagel, A. Erhöhte zerebrale Erregbarkeit und "spreading depression". Nervenarzt 74, 869–874 (2003). https://doi.org/10.1007/s00115-003-1538-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00115-003-1538-x